T. Shaw3, Lincoln, Ishani Hariprasad, Leonard V. Messner, Chandani A. Bansal, Sidney A. Schechet, and Janette Pérez. “Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature”. BOHR International Journal of Current Research in Optometry and Ophthalmology 1, no. 1 (October 7, 2022): 74–79. Accessed May 19, 2024. https://journals.bohrpub.com/index.php/bijcroo/article/view/108.